News-Papers
Testimonial
Video Gallery
Combination of isotretinoin and calcitriol for precancerous and cancerous skin lesions
Published on Friday, 21 July 2017
Combination of isotretinoin and calcitriol for precancerous and cancerous skin lesions
See also:
- All-Trans-Retinoic Acid (ATRA - analogues and/or derivatives);
- Solution of retinoids in vitamin E in the Di Bella Method biological multitherapy;
- Vitamin D (analogues and/or derivatives) and cancer;
- Large B-cells Non-Hodgkin's Lymphoma, Stage IV-AE: a Case Report;
Search
Follow us...
Latest
- Effect of the preventive-therapeutic administration of melatonin on mammary tumour-bearing animals
- A role of somatostatin analogues in the treatment of patients with hormone-refractory prostate cancer
- Effect of Melatonin on Tumor Growth and Angiogenesis in Xenograft Model of Breast Cancer
- Blocking dopamine receptor 2 decreases gastrin levels in H. pylori-infected mice through increasing gastric somatostatin content
- Beneficial properties of melatonin in an experimental model of pancreatic cancer
- Combinatory Effects of Indoximod and Melatonin Alleviate Myeloid Derived Suppressor Cells Driven Triple Negative Breast Cancer Progression and Metastasis
- Antitumour activity of melatonin in a mouse model of human prostate cancer: relationship with hypoxia signalling
- Vitamin D decreases tumor cell growth and invasiveness in primary malignant bone tumors in vitro
- Five years survival in metastatic non-small cell lung cancer patients treated with chemotherapy alone or chemotherapy and melatonin: a randomized trial
- Synergistic In Vitro Effects of Minor Phytocannabinoids and Melatonin Combinations Against Human Glioblastoma Cells
- Melatonin as a Promising Agent to Treat Ovarian Cancer: Molecular Mechanisms
- Pharmacologic targeting of the dopamine D2 receptor impacts the efficacy of immune checkpoint blockade in melanoma
- Dose-Dependency of Antitumor Effects of the Pineal Hormone Melatonin in Untreatable Metastatic Solid Tumor Patients
- Impaired redox adaptation through SLC38A5-dependent glutamine metabolism contributes to melatonin-mediated anoikis sensitivity and metastasis suppression in bone cancer
- Does the use of melatonin overcome drug resistance in cancer chemotherapy?
- Adjuvant chemotherapy with melatonin for targeting human cancers: A review
- A Preliminary Phase-2 Study with very High-Dose of Melatonin (1000 mg/day) in Untreatable Advanced Cancer Patients Already Progression on Previous Palliative Therapy with High-Dose Melatonin
- Melatonin and Vitamins: A Promising Combination to Augment Conventional Anticancer Therapies
Most Read
- The Di Bella Method (DBM)
- About melatonin - 1996
- All-trans-retinoic acid and cancer
- Biography
- Chronic Lymphocytic Leukemia: 4 patients, long-lasting remission
- The Di Bella Method Increases by the 30% the survival rate for Pancreas tumors and for this reason should be proposed as first line therapy for this type of cancer
- Somatostatin in oncology, the overlooked evidences
- Treatment of Low-grade Non-Hodgkin’s Lymphomas at Advanced Stage
- How effective is chemo therapy?
- Complete objective response to biological therapy of plurifocal breast carcinoma
- Bibliography
- Large B-cells Non-Hodgkin's Lymphoma, Stage IV-AE: a Case Report
- Non-Hodgkin's Lymphoma, Stage III-B-E: a Case Report
- Vademecum
- Frequently Asked Questions
- Declaration recommends eliminate the use of Impact factor for research evaluation
- Non–Small-Cell Lung Cancer Patients with Low Performance Status: study on 28 patients
- Breast cancer: study on 122 cases. The Di Bella Method (DBM) improved survival, objective response and performance status in a retrospective observational clinical study on 122 cases of breast cancer